9-98807718-G-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_024642.5(GALNT12):​c.20G>T​(p.Arg7Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000909 in 1,176,796 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R7W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00041 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000045 ( 0 hom. )

Consequence

GALNT12
NM_024642.5 missense

Scores

2
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 0.989

Publications

0 publications found
Variant links:
Genes affected
GALNT12 (HGNC:19877): (polypeptide N-acetylgalactosaminyltransferase 12) This gene encodes a member of a family of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases, which catalyze the transfer of N-acetylgalactosamine (GalNAc) from UDP-GalNAc to a serine or threonine residue on a polypeptide acceptor in the initial step of O-linked protein glycosylation. Mutations in this gene are associated with an increased susceptibility to colorectal cancer.[provided by RefSeq, Mar 2011]
GALNT12 Gene-Disease associations (from GenCC):
  • colorectal cancer, susceptibility to, 1
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.067785084).
BP6
Variant 9-98807718-G-T is Benign according to our data. Variant chr9-98807718-G-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 241511.
BS2
High AC in GnomAd4 at 61 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GALNT12NM_024642.5 linkc.20G>T p.Arg7Leu missense_variant Exon 1 of 10 ENST00000375011.4 NP_078918.3
LOC124902229XR_007061689.1 linkn.-138C>A upstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GALNT12ENST00000375011.4 linkc.20G>T p.Arg7Leu missense_variant Exon 1 of 10 1 NM_024642.5 ENSP00000364150.3
ENSG00000285706ENST00000647710.1 linkn.-154C>A upstream_gene_variant

Frequencies

GnomAD3 genomes
AF:
0.000406
AC:
61
AN:
150328
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00143
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000662
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000148
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00
AC:
0
AN:
16200
AF XY:
0.00
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000448
AC:
46
AN:
1026360
Hom.:
0
Cov.:
30
AF XY:
0.0000465
AC XY:
23
AN XY:
494698
show subpopulations
African (AFR)
AF:
0.00186
AC:
37
AN:
19850
American (AMR)
AF:
0.00
AC:
0
AN:
7886
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
11388
East Asian (EAS)
AF:
0.000376
AC:
6
AN:
15940
South Asian (SAS)
AF:
0.00
AC:
0
AN:
31678
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
15770
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2506
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
883480
Other (OTH)
AF:
0.0000792
AC:
3
AN:
37862
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000405
AC:
61
AN:
150436
Hom.:
0
Cov.:
32
AF XY:
0.000422
AC XY:
31
AN XY:
73482
show subpopulations
African (AFR)
AF:
0.00143
AC:
59
AN:
41378
American (AMR)
AF:
0.0000661
AC:
1
AN:
15118
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3440
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5138
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9882
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0000148
AC:
1
AN:
67360
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.000329

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Sep 18, 2023
Quest Diagnostics Nichols Institute San Juan Capistrano
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 11, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Uncertain:1
Oct 09, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.20G>T (p.R7L) alteration is located in exon 1 (coding exon 1) of the GALNT12 gene. This alteration results from a G to T substitution at nucleotide position 20, causing the arginine (R) at amino acid position 7 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

GALNT12-related disorder Benign:1
Jul 12, 2024
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
21
DANN
Benign
0.90
DEOGEN2
Benign
0.013
T
Eigen
Benign
-0.45
Eigen_PC
Benign
-0.42
FATHMM_MKL
Benign
0.64
D
LIST_S2
Benign
0.50
T
M_CAP
Pathogenic
0.40
D
MetaRNN
Benign
0.068
T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
0.0
N
PhyloP100
0.99
PrimateAI
Pathogenic
0.86
D
PROVEAN
Benign
-0.030
N
REVEL
Benign
0.14
Sift
Benign
0.24
T
Sift4G
Benign
0.35
T
Polyphen
0.099
B
Vest4
0.23
MutPred
0.47
Loss of disorder (P = 0.0284);
MVP
0.46
MPC
2.1
ClinPred
0.12
T
GERP RS
3.3
PromoterAI
-0.028
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.0
Varity_R
0.13
gMVP
0.48
Mutation Taster
=81/19
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs568625965; hg19: chr9-101570000; API